AI Trend Insights
Evidence-led trend reports that connect public signals to practical tools and product decisions.
finance decision
First Commonwealth Posts Higher Year-Over-Year Diluted EPS and Net Income on Both the Quarter and the Six-Month Year-to-Date Period
FIRST COMMONWEALTH FINANCIAL CORP /PA/ filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was $82,137,000 for the six months ended June 30, 2026, up from $66,098,000 a year earlier. Earnings Per Share, Diluted was $0.81 per diluted share for the six months ended June 30, 2026, up from $0.64 per diluted share a year earlier. Accretion (Amortization) of Discounts and Premiums, Investments was $140,000 for the six months ended June 30, 2026, up from -$18,000 a year earlier. APIC, Share-based Payment Arrangement, Recognition and Exercise was $1,085,000 for the six months ended June 30, 2026, up from $1,065,000 a year earlier. Amortization of Debt Discount (Premium) was -$806,000 for the six months ended June 30, 2026, down from $0 a year earlier.
finance decision
CECO Environmental Posts Higher Revenue but Swings to Loss on All Three Profitability Lines for Both the Quarter and Six-Month Year-to-Date Period
CECO ENVIRONMENTAL CORP filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was -$35,166,000 for the six months ended June 30, 2026, down from $45,494,000 a year earlier, swinging from a prior-year profit to a loss. Operating Income (Loss) was -$31,302,000 for the six months ended June 30, 2026, down from $79,930,000 a year earlier, swinging from a prior-year profit to a loss. Earnings Per Share, Diluted was -$0.89 per diluted share for the six months ended June 30, 2026, down from $1.24 per diluted share a year earlier, swinging from a prior-year profit to a loss.
finance decision
Tredegar quarterly earnings rise year over year as six-month net income softens and operating cash flow reverses sign
TREDEGAR CORP filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was $11,678,000 for the six months ended June 30, 2026, down from $11,832,000 a year earlier. Earnings Per Share, Diluted was $0.34 per diluted share for the six months ended June 30, 2026, level with $0.34 per diluted share a year earlier. Net Cash Provided by (Used in) Financing Activities was $10,938,000 for the six months ended June 30, 2026, up from -$569,000 a year earlier. Net Cash Provided by (Used in) Investing Activities was -$8,701,000 for the six months ended June 30, 2026, down from $6,101,000 a year earlier.
finance decision
BioLife Solutions Reports Loss-to-Profit Swing on All Three Profitability Lines for Both the Quarter and Six-Month Year-to-Date Period
BIOLIFE SOLUTIONS INC filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was $46,290,000 for the six months ended June 30, 2026, up from -$16,286,000 a year earlier, swinging from a prior-year loss to a profit. Operating Income (Loss) was $1,725,000 for the six months ended June 30, 2026, up from -$16,624,000 a year earlier, swinging from a prior-year loss to a profit. Earnings Per Share, Diluted was $0.94 per diluted share for the six months ended June 30, 2026, up from -$0.34 per diluted share a year earlier, swinging from a prior-year loss to a profit.
finance decision
WSFS Financial Corporation Posts Higher Year-Over-Year Diluted EPS and Net Income for Both the Quarter and the Six-Month Year-to-Date Period
WSFS FINANCIAL CORP filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was $171,225,000 for the six months ended June 30, 2026, up from $138,222,000 a year earlier. Earnings Per Share, Diluted was $3.26 per diluted share for the six months ended June 30, 2026, up from $2.39 per diluted share a year earlier. APIC, Share-based Payment Arrangement, Increase for Cost Recognition was $7,108,000 for the six months ended June 30, 2026, up from $6,327,000 a year earlier. Net Cash Provided by (Used in) Financing Activities was $1,190,631,000 for the six months ended June 30, 2026, up from -$143,015,000 a year earlier.
finance decision
Microchip Technology Posts Higher Revenue, Operating Income, and a Return to Profitability Versus Prior-Year Quarter
MICROCHIP TECHNOLOGY INC filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was $229,800,000 for the three months ended June 30, 2026, up from -$18,600,000 a year earlier, swinging from a prior-year loss to a profit. Earnings Per Share, Diluted was $0.37 per diluted share for the three months ended June 30, 2026, up from -$0.09 per diluted share a year earlier, swinging from a prior-year loss to a profit. Revenue from Contract with Customer, Excluding Assessed Tax was $1,484,700,000 for the three months ended June 30, 2026, up from $1,075,500,000 a year earlier. Operating Income (Loss) was $336,800,000 for the three months ended June 30, 2026, up from $32,100,000 a year earlier.
finance decision
Orrstown Financial Services Reports Higher Year-Over-Year Diluted EPS and Net Income for Both the Quarter and the Six-Month Year-to-Date Window
ORRSTOWN FINANCIAL SERVICES INC filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was $42,967,000 for the six months ended June 30, 2026, up from $37,499,000 a year earlier. Earnings Per Share, Diluted was $2.21 per diluted share for the six months ended June 30, 2026, up from $1.94 per diluted share a year earlier. Accretion (Amortization) of Discounts and Premiums, Investments was $9,318,000 for the six months ended June 30, 2026, down from $11,949,000 a year earlier. Net Cash Provided by (Used in) Financing Activities was $31,360,000 for the six months ended June 30, 2026, up from -$92,239,000 a year earlier.
finance decision
Heron Therapeutics interim report shows every reported income line in the red, with the half-year profit-to-loss swing as the binding signal
HERON THERAPEUTICS, INC. /DE/ filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was -$13,600,000 for the six months ended June 30, 2026, down from $254,000 a year earlier, swinging from a prior-year profit to a loss. Operating Income (Loss) was -$6,809,000 for the six months ended June 30, 2026, down from $1,517,000 a year earlier, swinging from a prior-year profit to a loss. Earnings Per Share, Diluted was -$0.07 per diluted share for the six months ended June 30, 2026, down from $0 per diluted share a year earlier, swinging from a prior-year profit to a loss.
finance decision
Perspective Therapeutics widens loss on every reported line in the latest interim filing
Perspective Therapeutics, Inc. filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was -$52,975,000 for the six months ended June 30, 2026, down from -$39,662,000 a year earlier. Operating Income (Loss) was -$57,539,000 for the six months ended June 30, 2026, down from -$45,871,000 a year earlier. Earnings Per Share, Diluted was -$0.47 per diluted share for the six months ended June 30, 2026, up from -$0.54 per diluted share a year earlier. Net Cash Provided by (Used in) Financing Activities was $164,511,000 for the six months ended June 30, 2026, up from $10,105,000 a year earlier. Net Cash Provided by (Used in) Investing Activities was -$94,534,000 for the six months ended June 30, 2026, down from -$1,301,000 a year earlier.
finance decision
L.B. Foster posts higher year-to-date and quarterly profit; quarter-level operating income softens despite a profit-to-profit transition
FOSTER L B CO filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was $4,612,000 for the six months ended June 30, 2026, up from $775,000 a year earlier. Operating Income (Loss) was $8,196,000 for the six months ended June 30, 2026, up from $5,755,000 a year earlier. Earnings Per Share, Diluted was $0.44 per diluted share for the six months ended June 30, 2026, up from $0.07 per diluted share a year earlier. Net Cash Provided by (Used in) Financing Activities was $605,000 for the six months ended June 30, 2026, down from $22,468,000 a year earlier. Net Cash Provided by (Used in) Investing Activities was -$6,521,000 for the six months ended June 30, 2026, down from -$5,199,000 a year earlier.